Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Aurobindo Pharma Community
NSEI:AUROPHARMA Community
1
Narratives
written by author
0
Comments
on narratives written by author
25
Fair Values set
on narratives written by author
Create a narrative
Aurobindo Pharma
Popular
Undervalued
Overvalued
Community Investing Ideas
Aurobindo Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts
Focus On Biosimilars And Complex Products Will Strengthen Future Prospects
Key Takeaways Strategic expansion in high-growth markets and operational efficiencies are set to drive future revenue growth and improved margins. Focus on complex products, capacity increases, and financial stability initiatives signals commitment to sustained profitability and earnings growth.
View narrative
₹1.47k
FV
22.0% undervalued
intrinsic discount
7.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
19
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
AUROPHARMA
AUROPHARMA
Aurobindo Pharma
Your Fair Value
₹
Current Price
₹1.15k
21.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
450b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹449.5b
Earnings ₹49.4b
Advanced
Set Fair Value